Teleflex Takes Aim At Critical Care Market With Arrow Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Arrow International's R&D capabilities and complementary business model enticed Teleflex to buy the critical care device maker for $2 billion as part of an ongoing transformation of its device business, the firms said July 23 (see chart: "1Teleflex-Arrow Deal Basics")
You may also be interested in...
People In Brief
Stryker CEO MacMillan is AdvaMed chair-elect
People In Brief
Stryker CEO MacMillan is AdvaMed chair-elect
Robotic Surgery’s Popularity Pushes Intuitive Surgical Stock Up 65% In Q3
Accelerating demand for Intuitive Surgical's da Vinci robotic surgical system procedures is driving the firm's stellar stock price growth, including a 65.7% leap in the third quarter